Aligos Therapeutics, Inc.

NASDAQ:ALGS

10.18 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q22018 Q1
Operating Activities:
Net Income 5.061-34.863-27.892-18.041-18.791-22.955-21.886-18.621-19.924-35.615-37.714-33.126-29.818-27.674-34.42-33.297-20.797-20.029-18.184-14.05-10.015-10.015-3.483-3.483
Depreciation & Amortization 0.610.6740.7750.6810.7690.8440.8970.9060.8890.9831.0130.9670.9250.8730.8830.8851.0970.460.6440.6260.5140.5140.3230.323
Deferred Income Tax 00-4.556-15.332-15.24900000000000.3310.161-0.0150-0.00100-0.425-0.425
Stock Based Compensation 2.0562.6482.5833.2093.1963.6643.4163.49143.7863.6513.6013.4492.7561.3011.0160.0520.6060.1480.1510.2270.2270.0450.045
Change In Working Capital 4.111-5.494-0.293-6.2020.643-3.6730.865-2.844-9.97610.403-4.4533.1882.402-5.78812.4992.7481.991-1.1752.5190.133000.4250.425
Accounts Receivables 000000000000000000000000
Change In Inventory 000000000000000000000000
Change In Accounts Payables 3.9770.325-0.423-0.30.419-1.9151.8060.169-0.9930.740.3991.122-1.332-0.502-3.8073.7660.215-0.3040.633-0.98000.7440.744
Other Working Capital 0.134-5.8190.13-5.9020.224-1.758-0.941-3.013-8.9839.663-4.8522.0663.734-5.28616.306-1.0181.776-0.8711.8861.11300-0.744-0.744
Other Non Cash Items -32.03217.966.72515.34915.816-0.267-0.075-0.069-0.0240.0090.0230.0020.0240.0370.05311.751-0.198-0.166-0.145-0.2730.3330.3331.6041.604
Operating Cash Flow -19.493-22.746-22.658-20.336-13.616-22.387-16.783-17.137-25.035-20.434-37.48-25.368-23.018-29.796-19.684-16.566-17.694-20.319-15.018-13.414-9.168-9.168-1.512-1.512
Investing Activities:
Investments In Property Plant And Equipment -0.007-0.069-0.007-0.0120.007-0.007-0.091-0.003-0.334-0.515-0.336-0.097-0.152-0.307-0.061-0.344-0.569-1.09-0.721-0.637-0.714-0.714-0.629-0.629
Acquisitions Net 000-0.0070.0070-11.695-32.4869.642000000000000000
Purchases Of Investments 0-88.5730-0.001-0.010-24.525-4.964-14.887-59.889-16.143-2.94300-0.00200-45.279-25.089-18.95600-16.693-16.693
Sales Maturities Of Investments 40000.011252036.2237.455.2450031010152715.522.6426.50000
Other Investing Activites 0000.00324.9972011.69532.486-9.642-59.889-16.1430.057101014.9982715.5-22.679-21.0897.54411.56111.56117.32217.322
Investing Cash Flow 39.993-88.642-0.007-0.00925.00419.99311.60432.483-9.976-60.404-16.479-0.049.8489.69314.93726.65614.931-23.769-21.816.90710.84710.847-17.322-17.322
Financing Activities:
Debt Repayment -0.016-0.019-0.004-0.021-0.047-0.024-0.027-0.028-0.029-0.031-0.02-0.022-0.019-0.018-0.012-0.018-0.017-0.011-0.016-0.0100-0-0
Common Stock Issued 0.297087.9400.4610.0230.020.0090.1120.0178.58477.9740.1140.096155.345000-0.2950000.0010.001
Common Stock Repurchased 0.4610-0.5720.1110.1110000000000.40500-0.405000000
Dividends Paid 00000000000000-41.035000000000
Other Financing Activities 0071.553-0.0210.414-0.0010.128-0.0190.1120.01-78.01277.9740.1140.09678.615-0.9310.0440.36885.5750.295-0.009-0.009-0-0
Financing Cash Flow 0.281-0.01987.936-0.0210.414-0.0010.121-0.0190.083-0.0210.55277.9520.0950.078193.318-0.9490.027-0.04885.2640.285-0.009-0.00900
Other Information:
Effect Of Forex Changes On Cash 0021.5685.128-26.6960000000000000000000
Net Change In Cash 20.781-111.40765.271-20.36711.802-2.395-5.05815.327-34.928-80.859-53.40752.544-13.075-20.025188.5719.141-2.736-44.13648.436-6.2221.6711.671-18.834-18.834
Cash At End Of Period 45.14824.367135.77470.50390.8779.06881.46286.5271.193106.121186.98240.387187.843200.918220.94332.37223.23125.96770.10321.66727.8891.6716.1376.137